PVLA — Palvella Therapeutics Share News
0.000.00%
Last trade - 00:00Pieris Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary
Brief: Pieris Pharmaceuticals Inc Says QTRLY Loss Per Share $0.24
Pieris Pharmaceuticals Inc expected to post a loss of 24 cents a share - Earnings Preview
Brief: Pieris Pharmaceuticals Files For Mixed Shelf Of Upto $250 Million
Pieris Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Brief: Pieris Pharmaceuticals Inc Posts Qtrly Loss Per Share 25 Cents
Pieris Pharmaceuticals Inc expected to post a loss of 26 cents a share - Earnings Preview
Brief: Kenneth Griffin Reports Passive Stake Of 5.2% In Pieris Pharmaceuticals Inc As Of June 25, 2021
U.S. STOCKS ON THE MOVE-Fedex, Nike, Carmax, Virgin Galactic
U.S. STOCKS ON THE MOVE-AbbVie, Southern Copper Corp, Morgan Stanley
Pieris Pharma rises on expanding lung disease pipeline, Bavarian govt grant
Brief: Pieris Pharmaceuticals - Announced Development Of Prs- 220, For Treatment Of Idiopathic Pulmonary Fibrosis
U.S. STOCKS ON THE MOVE-Sabre Corp, GameStop, Red Robin Gourmet Burgers
U.S. STOCKS ON THE MOVE-Ford Motor, Gap, CVS Health
U.S. STOCKS ON THE MOVE-Gamestop, Nabriva Therapeutics, Carlotz
U.S. STOCKS ON THE MOVE-Larimar Therapeutics, GSX Techedu, Riot Blockchain
Pieris Pharmaceuticals: Soars as co's stock draws retail traders' interest
U.S. STOCKS ON THE MOVE-Vimeo, Moderna, Pieris Pharmaceuticals, Novan, Virgin Galactic
U.S. STOCKS ON THE MOVE-Novan, Lordstown Motors, Shake Shack, United Airlines